pfizer glp 1 Pfizer, Novo Nordisk bidding war is just the latest escalation of a lucrative GLP-1 race Pfizer dips on new data

Description

Cardiovascular risk classification was based on the eligibility criteria used in each cardiovascular outcome trial, rather than a single risk prediction tool such as the Framingham Risk Score

Zhao, M

Its doing 2 different things

What theyre saying: While the new generation of incretin therapies have been revolutionary for patients living with obesity, bimagrumab addresses a critical unmet need as a therapeutic that targets fat loss while building muscle mass. Versanis CEO Mark Pruzanski The solo act The drug: Altimmunes pemvidutide is a combination GLP-1 agonist and glucagon agonist